Steven M. Frisch, Ph.D., Professor of Biochemistry at WVU School of Medicine, has been invited to be a member of the Department of Defense Ovarian Cancer Research Program Review Committee, for an annual term, beginning September 01, 2020.
Membership on a review section represents a major commitment of professional time and energy as well as a unique opportunity to contribute to the national biomedical research effort. These functions are of great value to medical and allied research in this country.
The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) was initiated in FY97 to support high-impact, cutting-edge research that fills unmet needs. The OCRP establishes priorities to target the most critical needs along the research development pipeline from basic to translational to clinical research, including clinical trials, and to push the field of ovarian cancer forward to our vision to “Eliminate ovarian cancer”.
Ovarian cancer is the fifth leading cause of cancer-related death in women and the deadliest of gynecologic cancers. In 2020 approximately 21,750 women will be diagnosed with ovarian cancer in the United States, and an estimated 13,940 will die from the disease.
Photo caption: Dr. Steven Frisch at a lab bench in 2016.
We have worked to make available a number of options on the Health Sciences campus for work, study and eating spaces.
All faculty are invited to attend the WVU Health Sciences Center Faculty Development Program presentation "Scholarly Research in Simulation" Nov. 10 from noon to 1 p.m.
"We are proud to partner with the National LGBT Cancer Network! Out: The National Cancer Survey, the national survey specifically for LGBTQI+ cancer survivors. Take the survey & help inform cancer care for the estimated 81,000 LGBTQI+ people who are diagnosed with cancer every year. https://bit.ly/35LyPlW #outsurvey"